CRT 2026

Panel Discussion | Who Should Get Embolic Protection Device During TAVR?

Moderator(s)

• 

  Hemal Gada, MD

  Structural Interventional Cardiologist
  UPMC Central PA

  Disclosure information not submitted.
• 

  Samir R. Kapadia, MD, FSCAI

  Chairman, Cardiovascular Medicine
  Cleveland Clinic
  Cleveland, Ohio, United States

  Disclosure information not submitted.
• 

  Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC

  Professor of Medicine
  Yale School of Medicine
  New Haven, Connecticut, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Neel Butala, MD

  Medical Director of Structural Heart Disease and Intervention
  Rocky Mountain Regional VA Medical Center

  Disclosure information not submitted.
• 

  Abhishek Chaturvedi, MD

  Interventional Cardiologist & Assistant Professor of Medicine
  West Virginia University Heart & Vascular Institute, United States

  Disclosure(s): No financial relationships to disclose
• 

  David J. Cohen, MD, FSCAI

  Director of Clinical and Outcomes Research
  Cardiovascular Research Foundation
  New York, New York, United States

  Disclosure(s): Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
• 

  Michael G. Dwyer, PhD

  Associate Professor of Neurology and Biomedical Informatics
  University at Buffalo
  Buffalo, New York, United States

  Disclosure information not submitted.